Ocean Genomics
The Intelligent Transcriptome
We are the transcriptomics AI company. We make the software and provide services that enable the advanced use of transcriptomic information to advance drug development, personalized medicine, and human health.
Key Applications
Solutions Spanning Drug Discovery & Development for Every Major Therapeutic Area
AI-driven multi-omic analysis brings new light to old questions and delivers unprecedented insights in previously unexplored territory.
Computationally-driven insights transcend what’s possible with manual analysis.
Discovery
Identify targets and mine biomarkers
Pre-Clinical
Assess assets, determine MoA, explore PK/PD studies, mine signatures
Clinical
Stratify patients, identify new subgroups, model patient response
Trial Salvage
Identify responding subgroups and provide biomarkers and rationale
Back-Translation
Discover new insights to incorporate into future programs
Indication Expansion
Discover signatures of response to identify additional potential patients
Founded By
Leaders in Genomics, AI & Machine Learning, and Computational Biology
Carl Kingsford, Ph.D.
Rob Patro, Ph.D.
Eric Schultz
Our Team has Developed Many of the Most Advanced and Widely Used RNA-Seq Software Applications
Validated Extensively
Our computational methods are backed by 4000+ Citations
Used Globally
Software created by our founders has been downloaded > 350K times
By Leading Organizations
Users include Johns Hopkins, Harvard, Roche, Pfizer, and Novartis
Our Vast Experience in Bioinformatics Method Development is Enabling the Next Generation of Commercial Software to Take Your Project to the Next Level
Join The Team
Career
Opportunities
RecentNews
Introducing a New Collection of Open-source Salmon Features!
Over the last year Ocean Genomics has, with the help of a grant from the Chan Zuckerberg Initiative, developed several new features and applications for
Ocean Genomics Awarded Grant For New Internship Program From The Chan Zuckerberg Initiative
Ocean Genomics has been awarded a grant by the Chan Zuckerberg Initiative (CZI) for the implementation of an internship program designed to increase the accessibility, inclusion and diversity of underrepresented communities in genomic and transcriptomic open-source biotechnology projects.